tiprankstipranks
Advertisement
Advertisement

HK:2256 Stock Latest News

Abbisko Grants 290,000 Share Options to Employees Under Post-IPO Scheme
Company AnnouncementsAbbisko Grants 290,000 Share Options to Employees Under Post-IPO Scheme
4d ago
2256
Abbisko Wins EMA Orphan Drug Status for Liver Cancer Therapy Irpagratinib
PremiumCompany Announcements
Abbisko Wins EMA Orphan Drug Status for Liver Cancer Therapy Irpagratinib
12d ago
2256
Abbisko Wins FDA IND Clearance for Pediatric Achondroplasia Drug ABSK061
PremiumCompany Announcements
Abbisko Wins FDA IND Clearance for Pediatric Achondroplasia Drug ABSK061
13d ago
2256
Abbisko Wins FDA Orphan Drug Status for Achondroplasia Candidate ABSK061
PremiumCompany Announcements
Abbisko Wins FDA Orphan Drug Status for Achondroplasia Candidate ABSK061
25d ago
2256
Abbisko Starts Phase II Trial of Irpagratinib Combo for Advanced Liver Cancer
PremiumCompany Announcements
Abbisko Starts Phase II Trial of Irpagratinib Combo for Advanced Liver Cancer
28d ago
2256
Abbisko Wins FDA Rare Pediatric Disease Status for Achondroplasia Drug ABSK061
PremiumCompany AnnouncementsAbbisko Wins FDA Rare Pediatric Disease Status for Achondroplasia Drug ABSK061
1M ago
2256
Abbisko’s TGCT Drug Pimicotinib Clears Key Global Milestone With Lancet Phase 3 Publication
Premium
Company Announcements
Abbisko’s TGCT Drug Pimicotinib Clears Key Global Milestone With Lancet Phase 3 Publication
1M ago
2256
Abbisko Advances KRAS G12D Cancer Program With First Patient Dosed in ABSK141 Trial
Premium
Company Announcements
Abbisko Advances KRAS G12D Cancer Program With First Patient Dosed in ABSK141 Trial
1M ago
2256
Abbisko Chairman Boosts Stake, Signalling Confidence While Maintaining Public Float
PremiumCompany Announcements
Abbisko Chairman Boosts Stake, Signalling Confidence While Maintaining Public Float
1M ago
2256
Abbisko Wins First China Drug Approval, Reshuffles Secretaries as Merck Deepens Tie-Up
PremiumCompany Announcements
Abbisko Wins First China Drug Approval, Reshuffles Secretaries as Merck Deepens Tie-Up
1M ago
2256
Abbisko Cayman Sets March Board Meeting to Approve 2025 Results and Consider Dividend
PremiumCompany Announcements
Abbisko Cayman Sets March Board Meeting to Approve 2025 Results and Consider Dividend
2M ago
2256
Abbisko Advances FGFR4 Inhibitor Irpagratinib With First U.S. Patient Dosed in Global HCC Trial
PremiumCompany Announcements
Abbisko Advances FGFR4 Inhibitor Irpagratinib With First U.S. Patient Dosed in Global HCC Trial
2M ago
2256
Abbisko Wins FDA Fast Track for Precision Liver Cancer Drug Irpagratinib
PremiumCompany AnnouncementsAbbisko Wins FDA Fast Track for Precision Liver Cancer Drug Irpagratinib
2M ago
2256
Abbisko’s TGCT Drug Pimicotinib Wins FDA NDA Acceptance After Strong Phase III Data
Premium
Company Announcements
Abbisko’s TGCT Drug Pimicotinib Wins FDA NDA Acceptance After Strong Phase III Data
3M ago
2256
Abbisko Wins NMPA IND Clearance for Novel KRAS G12D Cancer Drug ABSK141
Premium
Company Announcements
Abbisko Wins NMPA IND Clearance for Novel KRAS G12D Cancer Drug ABSK141
4M ago
2256
Abbisko Wins First Global Approval for TGCT Drug Pimicotinib in China
PremiumCompany Announcements
Abbisko Wins First Global Approval for TGCT Drug Pimicotinib in China
4M ago
2256
Abbisko Therapeutics Advances FGFR2/3 Inhibitor for Achondroplasia Treatment
PremiumCompany Announcements
Abbisko Therapeutics Advances FGFR2/3 Inhibitor for Achondroplasia Treatment
4M ago
2256
Abbisko Therapeutics Reports Positive Phase II Results for NSCLC Treatment
PremiumCompany Announcements
Abbisko Therapeutics Reports Positive Phase II Results for NSCLC Treatment
4M ago
2256
Abbisko Therapeutics Secures FDA Clearance for Pioneering Cancer Drug
PremiumCompany Announcements
Abbisko Therapeutics Secures FDA Clearance for Pioneering Cancer Drug
4M ago
2256
Abbisko Therapeutics Showcases Promising Phase III Results for TGCT Treatment
PremiumCompany AnnouncementsAbbisko Therapeutics Showcases Promising Phase III Results for TGCT Treatment
5M ago
2256
Abbisko Therapeutics Advances Phase II Study for NSCLC Treatment
Premium
Company Announcements
Abbisko Therapeutics Advances Phase II Study for NSCLC Treatment
5M ago
2256
Abbisko Therapeutics Unveils Promising Preclinical Cancer Drug Findings
Premium
Company Announcements
Abbisko Therapeutics Unveils Promising Preclinical Cancer Drug Findings
6M ago
2256

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >